Sleep experts close in on the optimal night’s sleep, reports the Wall Street Journal in both a written and video WSJ Live segment.
Jazz Pharmaceuticals plc and Concert Pharmaceuticals Inc have initiated the first Phase 1 clinical trial of JZP-386. JZP-386 is a deuterium-containing analog of sodium oxybate—the active ingredient in Xyrem (sodium oxybate) oral solution.
A New York Times writer compares an in-lab sleep study to a Novasom at-home test. The patient is much more impressed with the home sleep test.
In Europe, about 1/3 of people suffer from sleep problems, but only 20% get medical treatment, reports Euronews in a televised segment.
The Society of Anesthesia and Sleep Medicine and the Anesthesia Closed Claims Project have established a registry to investigate unanticipated perioperative deaths and near misses in patients with obstructive sleep apnea (OSA).
In light of a recent news article discussing mandatory sleep apnea tests for transportation operators as a means of reducing accidents, trucking company Prime Inc released a statement noting the company’s efforts to reduce sleep apnea-related accidents.
Sleep Review and Needham & Co’s 3rd quarter 2014 survey results show improvements in key areas.
While not in the top 10, veterans’ sleep apnea disability claims have soared since 2003, reports the Los Angeles Times.
The insurability of sleep apnea has improved drastically in the last decade, according to online life insurance comparison service YourLifeSolution.com.
This article in USA Today may be a great conversation starter between you and your patients about the link between sleep loss and weight gain.